These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20980172)

  • 1. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine thrombin and the clinical consequence of antibody development.
    Cronstein BN
    J Am Coll Surg; 2008 Jan; 206(1):199; author reply 199-200. PubMed ID: 18155591
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
    Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
    J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
    Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J
    Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical recombinant human thrombin in surgical hemostasis.
    Bowman LJ; Anderson CD; Chapman WC
    Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical thrombins: benefits and risks.
    Lomax C; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.
    Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA;
    J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
    Adams JD; Jones S; Brost BC
    J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine thrombin: history, use, and risk in the surgical patient.
    Diesen DL; Lawson JH
    Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of three stand-alone topical thrombins for surgical hemostasis.
    Cheng CM; Meyer-Massetti C; Kayser SR
    Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired factor V inhibitor: a common and avoidable complication of topical bovine thrombin application.
    Kirkeby KM; Aronowitz P
    Am J Med; 2005 Jul; 118(7):805. PubMed ID: 15989925
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
    He Zhu ; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):273-80. PubMed ID: 20547555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of various thrombin products with anti-rabbit antibodies to bovine, human, and recombinant thrombin.
    Sadeghi N; Zhu H; Setty SK; Cunanan J; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):243-8. PubMed ID: 22345489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coagulation cascade and surgical hemostasis. Introduction.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.